ARTemis: A randomised trial of bevacizumab with neoadjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer—Primary endpoint, pathological complete response (pCR).
Helena Margaret Earl
Honoraria - Roche
Research Funding - Roche/Genentech
Louise Hiller
No relevant relationships to disclose
Clare Blenkinsop
No relevant relationships to disclose
Louise Grybowicz
No relevant relationships to disclose
Anne-Laure Vallier
No relevant relationships to disclose
Jean Abraham
No relevant relationships to disclose
Jeremy Thomas
No relevant relationships to disclose
Elena Provenzano
No relevant relationships to disclose
Luke Hughes-Davies
No relevant relationships to disclose
Karen McAdam
Honoraria - Amgen
Steve Chan
Honoraria - advisory board
Rizvana Ahmad
No relevant relationships to disclose
Tamas Hickish
Honoraria - advisory board
Stephen Houston
Honoraria - Roche
Daniel Rea
No relevant relationships to disclose
John M. S. Bartlett
Research Funding - Roche
Carlos Caldas
No relevant relationships to disclose
David A. Cameron
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Other Remuneration - Roche
Janet Dunn
No relevant relationships to disclose
Richard L Hayward
Research Funding - Roche